Large Clinical Trials Change Experts Minds On Prostate Cancer Screening | Latest News RSS feed

Large Clinical Trials Change Experts Minds On Prostate Cancer Screening - Latest News

Large clinical trials change experts’ minds on prostate cancer screening

Prostate cancer screening is now something to consider for men aged 55 to 69, according to the federal panel tasked with making recommendations for such preventative care options. In a finalized recom... read more

Prostate-Cancer Screening: Men Should Forgo PSA Testing, Panel Advises

The USPSTF, which in 2009 recommended that women delay routine mammograms until age 50, based its prostate-cancer-screening guidelines on a review of previous research, including two large studies ... ... read more

Overdiagnosis: when finding cancer can do more harm than good

Overdiagnosis is one of the key things to consider when working out the balance of possible benefits and harms of cancer screening. Keep in mind ... A large study from 2013 looked at the results of di... read more

Looking for another news?

How One Family Tackled The 'Team Sport' Of Tough Prostate Cancer Choices

My first reaction to the option of active surveillance was "No." "No, no, no. No." A cancer diagnosis without any treatment seemed ludicrous. Even for prostate cancer, known as a sloth in the oncology ... read more

A Controversial New Study Says Mammograms Don't Save Lives. Should We Believe It?

In late 2009, a government-appointed panel of medical experts came under withering attack for suggesting that Americans were getting too many mammograms—that early screening ... clinical trials of mam... read more

Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q4 2017 Results - Earnings Call Transcript

Our Phase 1/2 trial of relacorilant to patients with pancreatic and other solid tumors; our trial of CORT125281 in castration resistant prostate cancer ... by independent outside experts experienced s... read more

Osteoporosis in Men: Undertreated and Overlooked

And screening for ... a physician and senior research scientist at Berkeley Madonna, Inc. in Berkeley, California. "Unique risk factors for men include low testosterone levels and use of androgen depr... read more

New Prostate Cancer Test Shows Greater Accuracy

A new, more accurate test to detect prostate cancer may soon change the way doctors screen ... "It is not ready for routine clinical use, but the results are exciting enough to do large-scale prospect... read more

Research: Having a Black Doctor Led Black Men to Receive More-Effective Care

They were the most reluctant to have services done in the beginning, and they were the most likely to change their minds after talking to a black doctor and to have more services done. This is meaning... read more

Does nanomedicine have a delivery problem?

They propose a 30-year plan to study the delivery problem in detail to help ... reported mixed results from a Phase II trial of their product BIND-014, a polymer-based particle that targets proteins o... read more

Chugai Pharmaceutical (CHGCF) Management on Q1 2017 Results - Earnings Call Transcript

Phase III studies were initiated for RG7446, atezolizumab, for ovarian cancer and prostate ... in my mind. So I would like to ask what your thought process was? Iida speaking. We understand that when ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us